کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5856236 | 1131972 | 2015 | 7 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Adverse food-drug interactions Adverse food-drug interactions](/preview/png/5856236.png)
- Combining bioactives with medicinal products increases the risk on adverse events.
- The position of products containing bioactives in law is not clear-cut.
- Adverse effects result from xenotiobic metabolism and pharmacodynamic interactions.
- The legal position of bioactives can be clarified by increasing molecular knowledge.
- Molecular knowledge on bioactives could also prevent serious adverse reactions.
Food supplements and herbal products are increasingly popular amongst consumers. This leads to increased risks of interactions between prescribed drugs and these products containing bioactive ingredients. From 1991 up to 2014, 55 cases of suspected adverse drug reactions due to concomitant intake of health-enhancing products and drugs were reported to Lareb, the Netherlands Pharmacovigilance Centre. An overview of these suspected interactions is presented and their potential mechanisms of action are described. Mainly during the metabolism of xenobiotics and due to the pharmacodynamics effects interactions seem to occur, which may result in adverse drug reactions. Where legislation is seen to distinct food and medicine, legislation concerning these different bioactive products is less clear-cut. This can only be resolved by increasing the molecular knowledge on bioactive substances and their potential interactions. Thereby potential interactions can be better understood and prevented on an individual level. By considering the dietary pattern and use of bioactive substances with prescribed medication, both health professionals and consumers will be increasingly aware of interactions and these interactive adverse effects can be prevented.
Journal: Regulatory Toxicology and Pharmacology - Volume 73, Issue 3, December 2015, Pages 859-865